<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:ns1="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001085146-24-001539</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001771015</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001623526</issuerCik>
        <issuerName>Stoke Therapeutics Inc</issuerName>
        <issuerCusip>86150R107</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <ns1:street1>3 Preston Ct</ns1:street1>
          <ns1:city>Bedford</ns1:city>
          <ns1:stateOrCountry>MA</ns1:stateOrCountry>
          <ns1:zipCode>01730</ns1:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Cowen Financial Products LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3173258</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3173258</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3173258</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Stoke Therapeutics Inc</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>3 Preston Ct, Bedford, MASSACHUSETTS
01730</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Cowen Financial Products LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>One Vanderbilt Avenue
New York, NY 10017</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Cowen Financial Products LLC - DELAWARE</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>3,173,258</amountBeneficiallyOwned>
        <classPercent>5.8</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Cowen Financial Products LLC - 3,173,258</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Cowen Financial Products LLC - 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Cowen Financial Products LLC - 3,173,258</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Cowen Financial Products LLC - 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Cowen Financial Products LLC</reportingPersonName>
      <signatureDetails>
        <signature>John Holmes</signature>
        <title>John Holmes / Chief Operating Officer</title>
        <date>07/29/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
